Diep Chieu B, Kleivi Kristine, Ribeiro Franclim R, Teixeira Manuel R, Lindgjaerde Ole C, Lothe Ragnhild A
Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Norway.
Genes Chromosomes Cancer. 2006 Jan;45(1):31-41. doi: 10.1002/gcc.20261.
To identify chromosomal aberrations that differentiate among the Dukes' stages of colorectal cancer (CRC) as well as those that are responsible for the progression into liver metastases, we performed a meta-analysis of data obtained from 31 comparative genomic hybridization (CGH) studies comprising a total of 859 CRCs. Individual copy number profiles for 373 primary tumors and 102 liver metastases were recorded and several statistical analyses, such as frequency, multivariate logistic regression, and trend tests, were performed. In addition, time of occurrence analysis was applied for the first time to copy number changes identified by CGH, and each genomic imbalance was thereby classified as an early or late event in colorectal tumorigenesis. By combining data from the different statistical tests, we present a novel genetic pathway for CRC progression that distinguishes the Dukes' stages and identifies early and late events in both primary carcinomas and liver metastases. Results from the combined analyses suggest that losses at 17p and 18 and gains of 8q, 13q, and 20 occur early in the establishment of primary CRCs, whereas loss of 4p is associated with the transition from Dukes' A to B-D. Deletion of 8p and gains of 7p and 17q are correlated with the transition from primary tumor to liver metastasis, whereas losses of 14q and gains of 1q, 11, 12p, and 19 are late events. We supplement these findings with a list of potential target genes for the specific alterations from a publicly available microarray expression dataset of CRC.
为了鉴别出能区分结直肠癌(CRC)不同杜克分期以及导致肝转移进展的染色体畸变,我们对来自31项比较基因组杂交(CGH)研究的数据进行了荟萃分析,这些研究共纳入859例CRC。记录了373例原发性肿瘤和102例肝转移灶的个体拷贝数图谱,并进行了多项统计分析,如频率分析、多变量逻辑回归分析和趋势检验。此外,首次将发生时间分析应用于CGH鉴定出的拷贝数变化,从而将每个基因组失衡归类为结直肠癌发生过程中的早期或晚期事件。通过整合不同统计检验的数据,我们提出了一种新的CRC进展遗传途径,该途径可区分杜克分期,并确定原发性癌和肝转移中的早期和晚期事件。综合分析结果表明,17p和18号染色体的缺失以及8q、13q和20号染色体的增益在原发性CRC形成早期出现,而4p缺失与从杜克A期向B - D期的转变相关。8p缺失以及7p和17q增益与从原发性肿瘤向肝转移的转变相关,而14q缺失以及1q、11、12p和19号染色体的增益则是晚期事件。我们从一个公开可用的CRC微阵列表达数据集中补充了这些特定改变的潜在靶基因列表,以支持这些发现。